BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 932 filers reported holding BAXTER INTL INC in Q1 2023. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $458,389 | -36.7% | 12,146 | -23.6% | 0.02% | -35.3% |
Q2 2023 | $724,312 | -83.5% | 15,898 | -85.3% | 0.03% | -85.4% |
Q1 2023 | $4,387,130 | -20.5% | 108,164 | -0.1% | 0.23% | -20.2% |
Q4 2022 | $5,516,788 | -7.2% | 108,236 | -2.0% | 0.29% | -15.9% |
Q3 2022 | $5,947,000 | -14.9% | 110,418 | +1.5% | 0.35% | -11.7% |
Q2 2022 | $6,989,000 | -14.8% | 108,802 | +2.8% | 0.39% | -7.5% |
Q1 2022 | $8,203,000 | -4.0% | 105,797 | +6.3% | 0.42% | -5.3% |
Q4 2021 | $8,542,000 | +13.8% | 99,513 | +6.7% | 0.45% | +0.2% |
Q3 2021 | $7,505,000 | +2.9% | 93,307 | +3.0% | 0.45% | +1.1% |
Q2 2021 | $7,291,000 | -2.1% | 90,569 | +2.6% | 0.44% | -9.2% |
Q1 2021 | $7,448,000 | +9.0% | 88,306 | +3.7% | 0.49% | +3.6% |
Q4 2020 | $6,830,000 | +10.2% | 85,115 | +10.5% | 0.47% | -2.3% |
Q3 2020 | $6,196,000 | +1.2% | 77,046 | +8.4% | 0.48% | -6.8% |
Q2 2020 | $6,120,000 | +14.1% | 71,090 | +7.7% | 0.52% | -3.5% |
Q1 2020 | $5,362,000 | +0.9% | 66,034 | +4.0% | 0.54% | +24.1% |
Q4 2019 | $5,312,000 | +1.5% | 63,523 | +6.1% | 0.43% | -8.1% |
Q3 2019 | $5,235,000 | +11.1% | 59,855 | +4.0% | 0.47% | +7.1% |
Q2 2019 | $4,713,000 | -14.7% | 57,546 | -15.3% | 0.44% | -20.6% |
Q1 2019 | $5,524,000 | +14.6% | 67,927 | -7.2% | 0.55% | +3.0% |
Q4 2018 | $4,819,000 | +7.8% | 73,223 | +26.3% | 0.54% | +18.0% |
Q3 2018 | $4,471,000 | +30.8% | 57,995 | +25.3% | 0.46% | +20.7% |
Q2 2018 | $3,417,000 | +34.7% | 46,273 | +18.6% | 0.38% | +30.4% |
Q1 2018 | $2,537,000 | +535.8% | 39,001 | +532.3% | 0.29% | +556.8% |
Q4 2017 | $399,000 | +74.2% | 6,168 | +69.5% | 0.04% | +63.0% |
Q3 2017 | $229,000 | +10.1% | 3,638 | +5.8% | 0.03% | +8.0% |
Q2 2017 | $208,000 | -16.8% | 3,438 | -4.0% | 0.02% | -37.5% |
Q2 2015 | $250,000 | -35.6% | 3,580 | -36.9% | 0.04% | -39.4% |
Q1 2015 | $388,000 | +22.8% | 5,678 | +31.7% | 0.07% | +17.9% |
Q4 2014 | $316,000 | -4.0% | 4,312 | -6.0% | 0.06% | -9.7% |
Q3 2014 | $329,000 | +4.4% | 4,585 | +5.2% | 0.06% | +1.6% |
Q2 2014 | $315,000 | +1.0% | 4,359 | +2.8% | 0.06% | +8.9% |
Q1 2014 | $312,000 | -9.6% | 4,240 | -14.6% | 0.06% | -11.1% |
Q4 2013 | $345,000 | -47.6% | 4,965 | -50.4% | 0.06% | -4.5% |
Q3 2013 | $658,000 | +100.0% | 10,000 | +110.3% | 0.07% | -1.5% |
Q2 2013 | $329,000 | – | 4,755 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |